Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Experimental Cell Research|March 15, 2011
Erythropoietin for oncology supportive careMatthew McKinney, Murat O ArcasoyClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectivesMurat O ArcasoyBritish Journal of Haematology|March 8, 2008
The non-haematopoietic biological effects of erythropoietinMurat O ArcasoyEuropean Journal of Internal Medicine|April 4, 2015
The clinical and laboratory evaluation of the patient with erythrocytosisGrace Lee, Murat O ArcasoyBritish Journal of Haematology|June 29, 2005
Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factorMurat O Arcasoy, Xiaohong JiangBiochemical and Biophysical Research Communications|January 26, 2007
Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosisPing Fu, Murat O ArcasoyBiochimica Et Biophysica Acta|May 10, 2005
Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domainMurat O Arcasoy, Aysen F KarayalClinical Advances in Hematology & Oncology : H&O|March 6, 2024
Recombinant interferon alfa in BCR/ABL-negative chronic myeloproliferative neoplasmsSandy El Bitar, Murat O ArcasoyBiochemical and Biophysical Research Communications|January 10, 2009
Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathwayPing Fu, Xiaohong Jiang, Murat O ArcasoyBiochemical and Biophysical Research Communications|July 25, 2003
Expression of erythropoietin receptor splice variants in human cancerMurat O Arcasoy, Xiaohong Jiang, Zishan A HaroonPageof 7